Display Settings:

Format

Send to:

Choose Destination
Proc Natl Acad Sci U S A. 1988 Sep;85(18):6612-6.

Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.

Author information

  • 1Max von Pettenkofer Institute, University of Munich, Federal Republic of Germany.

Abstract

The protease encoded by the human immunodeficiency virus (HIV) processes the viral gag and gag-pol protein precursor by posttranslational cleavage. In this study we have demonstrated by site-specific mutagenesis (Asp----Thr) and by pepstatin A inhibition that the recombinant HIV protease is an aspartic-type protease. Furthermore, incubation of HIV-infected H9 cells with pepstatin A inhibited part of the intracellular processing of the HIV gag protein yet had no apparent toxicity on HIV-infected cells during 48 hr of incubation.

PMID:
3045820
[PubMed - indexed for MEDLINE]
PMCID:
PMC282027
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk